Live feed07:05:00·12dPRReleasevia QuantisnowAlterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System AtrophyByQuantisnow·Wall Street's wire, on your screen.ATHE· Alterity Therapeutics LimitedHealth Care
